Cargando…
Follicular Lymphoma Secondary to Chronic Myeloid Leukemia During Treatment With Imatinib
Tyrosine kinase inhibitors (TKIs) remain the mainstay of treatment for those with chronic myeloid leukemia (CML); nonetheless, there is concern over the possibility of additional cancers as a result of TKI use. There are not many cases in the literature where tyrosine kinase treatment caused a patie...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790149/ https://www.ncbi.nlm.nih.gov/pubmed/36579283 http://dx.doi.org/10.7759/cureus.31884 |